SBC Medical [SBC] vs Equifax [EFX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: SBC Medical Group Holdings Inc. wins in 13 metrics, Equifax Inc. wins in 6 metrics, with 0 ties. SBC Medical Group Holdings Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | SBC Medical Group Holdings Inc. | Equifax Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.80 | 31.45 | SBC Medical Group Holdings Inc. |
| Price-to-Book Ratio | 1.41 | 4.69 | SBC Medical Group Holdings Inc. |
| Debt-to-Equity Ratio | 19.61 | 113.35 | SBC Medical Group Holdings Inc. |
| PEG Ratio | 6.80 | 0.93 | Equifax Inc. |
| EV/EBITDA | 3.58 | 13.78 | SBC Medical Group Holdings Inc. |
| Profit Margin (TTM) | 29.37% | 11.12% | SBC Medical Group Holdings Inc. |
| Operating Margin (TTM) | 32.47% | 17.45% | SBC Medical Group Holdings Inc. |
| EBITDA Margin (TTM) | 32.47% | 17.45% | SBC Medical Group Holdings Inc. |
| Return on Equity | 22.28% | 14.37% | SBC Medical Group Holdings Inc. |
| Return on Assets (TTM) | 13.05% | 6.27% | SBC Medical Group Holdings Inc. |
| Free Cash Flow (TTM) | $21.96M | $1.13B | Equifax Inc. |
| Dividend Yield | N/A | 1.08% | N/A |
| 1-Year Return | -37.43% | -37.25% | Equifax Inc. |
| Price-to-Sales Ratio (TTM) | 2.01 | 3.43 | SBC Medical Group Holdings Inc. |
| Enterprise Value | $251.33M | $26.58B | Equifax Inc. |
| EV/Revenue Ratio | 1.45 | 4.23 | SBC Medical Group Holdings Inc. |
| Gross Profit Margin (TTM) | 73.11% | 53.48% | SBC Medical Group Holdings Inc. |
| Revenue per Share (TTM) | $2 | $51 | Equifax Inc. |
| Earnings per Share (Diluted) | $0.50 | $5.68 | Equifax Inc. |
| Beta (Stock Volatility) | 0.99 | N/A | N/A |
| Short % of Float | 2.34% | 4.62% | SBC Medical Group Holdings Inc. |
SBC Medical Group Holdings Inc. vs Equifax Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| SBC Medical Group Holdings Inc. | -4.06% | 2.56% | -2.44% | -17.95% | -9.60% | -26.10% |
| Equifax Inc. | -3.38% | 8.17% | 2.25% | -15.34% | -15.60% | -17.72% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| SBC Medical Group Holdings Inc. | -37.43% | -70.92% | -70.92% | -83.37% | -99.98% | -99.99% |
| Equifax Inc. | -37.25% | -22.40% | -28.97% | 32.42% | 357.60% | 359.25% |
Performance & Financial Health Analysis: SBC Medical Group Holdings Inc. vs Equifax Inc.
| Metric | SBC | EFX |
|---|---|---|
| Market Information | ||
| Market Cap | $343.63M | $21.10B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 195,499 | 1,824,577 |
| 90 Day Avg. Volume | 94,543 | 1,744,279 |
| Last Close | $3.07 | $170.16 |
| 52 Week Range | $2.78 - $5.75 | $156.47 - $275.91 |
| % from 52W High | -46.61% | -38.33% |
| All-Time High | $49,900.00 (Jun 21, 2010) | $309.63 (Sep 16, 2024) |
| % from All-Time High | -99.99% | -45.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.11% | 0.14% |
| Quarterly Earnings Growth | 1.17% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.11% |
| Operating Margin (TTM) | 0.32% | 0.17% |
| Return on Equity (TTM) | 0.22% | 0.14% |
| Debt to Equity (MRQ) | 19.61 | 113.35 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.42 | $38.06 |
| Cash per Share (MRQ) | $1.60 | $1.54 |
| Operating Cash Flow (TTM) | $24.67M | $1.63B |
| Levered Free Cash Flow (TTM) | $25.41M | $1.01B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.08% |
| Last 12-Month Dividend | N/A | $2.06 |
Valuation & Enterprise Metrics Analysis: SBC Medical Group Holdings Inc. vs Equifax Inc.
| Metric | SBC (Apr 26, 2026) | EFX (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.80 | 31.45 |
| Forward P/E | 6.80 | 17.39 |
| PEG Ratio | 6.80 | 0.93 |
| Price to Sales (TTM) | 2.01 | 3.43 |
| Price to Book (MRQ) | 1.41 | 4.69 |
| Market Capitalization | ||
| Market Capitalization | $343.63M | $21.10B |
| Enterprise Value | $251.33M | $26.58B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.45 | 4.23 |
| Enterprise to EBITDA | 3.58 | 13.78 |
| Risk & Other Metrics | ||
| Beta | 0.99 | N/A |
| Book Value per Share (MRQ) | $2.42 | $38.06 |
Financial Statements Comparison: SBC Medical Group Holdings Inc. vs Equifax Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SBC (2025) | EFX (2025) |
|---|---|---|
| Revenue/Sales | 173.61M | 6.07B |
| Cost of Goods Sold | 46.32M | 2.65B |
| COGS % of Revenue | 26.7% | 43.6% |
| Gross Profit | 127.28M | 3.43B |
| Gross Margin | 73.3% | 56.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 67.49M | 1.10B |
| Operating Margin | 38.9% | 18.0% |
| EBITDA | 74.16M | 1.83B |
| EBITDA Margin | 42.7% | 30.2% |
| Pre-Tax Income | 82.07M | 894.90M |
| Pre-Tax Income % of Revenue | 47.3% | 14.7% |
| Income Tax | 31.02M | 230.60M |
| Income Tax % of Revenue | 17.9% | 3.8% |
| Net Income (Profit) | 51.05M | 664.30M |
| Profit Margin | 29.4% | 10.9% |
Balance Sheet & Liquidity Metrics
| Metric | SBC (2025) | EFX (2025) |
|---|---|---|
| Cash & Equivalents | 163.77M | 180.80M |
| Total Current Assets | 231.22M | 1.41B |
| Total Current Assets % of Revenue | 133.2% | 23.2% |
| Total Current Liabilities | 61.12M | 2.34B |
| Total Current Liabilities % of Revenue | 35.2% | 38.4% |
| Long-Term Debt | 37.99M | 4.06B |
| Long-Term Debt % of Revenue | 21.9% | 66.8% |
| Total Shareholders Equity | 263.30M | 4.74B |
| Retained Earnings | 240.45M | 6.45B |
| Retained Earnings % of Revenue | 138.5% | 106.1% |
| Property, Plant & Equipment | 8.82M | 299.60M |
Cash Flow Statement Comparison
| Metric | SBC (2025) | EFX (2025) |
|---|---|---|
| Operating Cash Flow | 50.77M | 1.62B |
| Operating Cash Flow % of Revenue | 29.2% | 26.6% |
| Capital Expenditures | 4.77M | N/A |
| Free Cash Flow | 21.96M | 1.13B |
| FCF Margin | 12.7% | 18.7% |
| Debt Repayment | -1.68M | -400.20M |
| Common Stock Repurchase | -5.00M | -927.50M |
Short Interest & Institutional Ownership Analysis
| Metric | SBC | EFX |
|---|---|---|
| Shares Short | 231,149 | 4.76M |
| Short Ratio | 6.42 | 3.04 |
| Short % of Float | 2.34% | 4.62% |
| Shares Outstanding | 102.58M | 119.30M |
| Float Shares | 91.42M | 118.80M |
| % Held by Insiders | 82.20% | 0.64% |
| % Held by Institutions | 1.31% | 100.16% |
| % Held by Public | 16.49% | -0.80% |
Dividend Analysis & Yield Comparison: SBC Medical Group Holdings Inc. vs Equifax Inc.
| Metric | SBC | EFX |
|---|---|---|
| Last 12-Month Dividend | N/A | $2.06 |
| Last 12-Month Dividend Yield | N/A | 1.08% |
| 3-Year Avg Annual Dividend | N/A | $1.73 |
| 3-Year Avg Dividend Yield | N/A | 0.19% |
| 3-Year Total Dividends | N/A | $5.18 |
| Ex-Dividend Date | N/A | Mar 09, 2026 |